指南与共识垂体与肾上腺疾病

单侧原发性醛固酮增多症的国际组织病理学共识

International Histopathology Consensus for Unilateral Primary Aldosteronism.
指南 / 共识 · J Clin Endocrinol Metab · 2021-01-01

该共识旨在规范单侧原发性醛固酮增多症(PA)肾上腺组织病理学特征的命名与定义。研究选取德国慕尼黑2015至2018年手术切除的37例肾上腺(来自90例患者),由5名病理学家(第1组)评估HE和CYP11B2免疫染色切片并达成共识,随后6名病理学家(第2组)用该共识评估第1组有诊断分歧的病例。使用CYP11B2免疫染色使5/37例(14%)的原始HE形态学诊断发生改变;第2组病理学家对第1组12例分歧中的11例达成一致。

要点

  • HISTALDO共识定义了与PA相关的组织病理学特征并标准化命名。
  • CYP11B2免疫染色使5/37例(14%)的原始HE形态学诊断发生改变。
  • 第2组病理学家对第1组12例分歧中的11例达成一致。

核心结论

  • HISTALDO共识有助于标准化命名并使病理学家对单侧PA的组织病理学诊断达成一致。
  • CYP11B2免疫组化应纳入常规临床诊断流程以定位可能的醛固酮产生来源。

研究设计与样本

  • 国际共识制定,由5名病理学家(第1组,来自德国、意大利、日本)评估37例手术切除肾上腺的HE和CYP11B2免疫染色切片并达成共识。
  • 随后6名病理学家(第2组,来自澳大利亚、巴西、加拿大、日本、英国、美国)用该共识评估第1组有组织病理学诊断分歧的所有肾上腺。
  • 手术肾上腺(n=37)来自德国慕尼黑2015至2018年手术的90例患者,选取以代表单侧PA的广泛组织学谱。

主要发现

  • 使用CYP11B2免疫染色使5/37例(14%)的原始HE形态学驱动诊断发生改变。
  • 使用共识标准,第2组病理学家对第1组12例分歧中的11例评估达成一致。

关键数值与推荐

  • 共识定义了与PA相关的组织病理学特征。
  • CYP11B2免疫染色使5/37例(14%)的原始HE形态学驱动诊断发生改变。
  • 第2组病理学家对第1组12例分歧中的11例达成一致。

临床怎么用

  • CYP11B2免疫组化应纳入常规临床诊断流程以定位可能的醛固酮产生来源。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Develop a consensus for the nomenclature and definition of adrenal histopathologic features in unilateral primary aldosteronism (PA). CONTEXT: Unilateral PA is the most common surgically treated form of hypertension. Morphologic examination combined with CYP11B2 (aldosterone synthase) immunostaining reveals diverse histopathologic features of lesions in the resected adrenals. PATIENTS AND METHODS: Surgically removed adrenals (n = 37) from 90 patients operated from 2015 to 2018 in Munich, Germany, were selected to represent the broad histologic spectrum of unilateral PA. Five pathologists (Group 1 from Germany, Italy, and Japan) evaluated the histopathology of hematoxylin-eosin (HE) and CYP11B2 immunostained sections, and a consensus was established to define the identifiable features. The consensus was subsequently used by 6 additional pathologists (Group 2 from Australia, Brazil, Canada, Japan, United Kingdom, United States) for the assessment of all adrenals with disagreement for histopathologic diagnoses among group 1 pathologists. RESULTS: Consensus was achieved to define histopathologic features associated with PA. Use of CYP11B2 immunostaining resulted in a change of the original HE morphology-driven diagnosis in 5 (14%) of 37 cases. Using the consensus criteria, group 2 pathologists agreed for the evaluation of 11 of the 12 cases of disagreement among group 1 pathologists. CONCLUSION: The HISTALDO (histopathology of primary aldosteronism) consensus is useful to standardize nomenclature and achieve consistency among pathologists for the histopathologic diagnosis of unilateral PA. CYP11B2 immunohistochemistry should be incorporated into the routine clinical diagnostic workup to localize the likely source of aldosterone production.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Williams TA, Gomez-Sanchez CE, Rainey WE, et al. International Histopathology Consensus for Unilateral Primary Aldosteronism. J Clin Endocrinol Metab. 2021. PMID: 32717746. doi:10.1210/clinem/dgaa484

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。